Inventor
PALMER JAMES T
US36 patents
⚠️ This page may combine multiple inventors who share the name “PALMER JAMES T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AXYS PHARM INC
10 patentsUS6287840B1Sep 11, 2001
Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
AXYS PHARM INC49 citations94
US7375134B2May 20, 2008
Cathepsin cysteine protease inhibitors
AXYS PHARM INC21 citations91
US6506733B1Jan 14, 2003
Compounds and compositions as protease inhibitors
AXYS PHARM INC40 citations91
US6030946AFeb 29, 2000
Reversible cysteine protease inhibitors
AXYS PHARM INC78 citations91
US6476026B1Nov 5, 2002
Compounds and compositions as protease inhibitors
AXYS PHARM INC27 citations90
US7012075B2Mar 14, 2006
Cathepsin cysteine protease inhibitors
AXYS PHARM INC52 citations86
US7973037B2Jul 5, 2011
Cathepsin cysteine protease inhibitors
AXYS PHARM INC12 citations83
US6593327B2Jul 15, 2003
Compounds and compositions as protease inhibitors
AXYS PHARM INC11 citations71
US7196099B2Mar 27, 2007
Compounds and compositions as cathepsin inhibitors
AXYS PHARM INC6 citations62
US7030116B2Apr 18, 2006
Compounds and compositions as cathepsin inhibitors
AXYS PHARM INC1 citations51
BIOMEA FUSION INC
4 patentsUS12018032B2Jun 25, 2024
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction
BIOMEA FUSION INC0 citations55
US12215113B2Feb 4, 2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide]
BIOMEA FUSION INC0 citations52
US12251385B2Mar 18, 2025
Covalent inhibitors of menin-MLL interaction for diabetes mellitus
BIOMEA FUSION INC0 citations51
US11945785B2Apr 2, 2024
Pyrazine compounds as inhibitors of FLT3
BIOMEA FUSION INC0 citations46